logo
episode-header-image
Aug 2023
1h 4m

PT430 – Maya Albert – Psychedelics for E...

PSYCHEDELICS TODAY
About this episode

In this episode, Joe interviews Maya Albert: Co-Founder of the Psyched conference, and Director of Operations at Tabula Rasa Ventures and the Synthesis Institute.

She shares her journey of how she became involved in the psychedelic space through her mother, and her personal experience as a patient in a clinical trial on psilocybin for the treatment of anorexia – a much more common and deadly affliction than most people realize. She discusses her involvement with the various psychedelic gatherings surrounding Davos and the World Economic Forum, as well as the work she’s doing with Tabula Rasa and some of their clients seeking to expand insurance coverage to psychedelic-assisted therapy. 

She discusses the Synthesis Institute’s recent struggles that shook up the psychedelic space, what they’re doing to save the company, how Retreat Guru has helped them, and the implications for the wider psychedelic movement. And she talks about much more: the legality and vetting process for training in Oregon and Colorado; truffles in the Netherlands vs. classic psilocybin; the idea of alcohol as poison and ‘Cali sober,’ and how can we all be more collaborative and not sling mud at each other?

Click here to head to the show notes page. 

Up next
Jul 8
PT 613 - Daniel Pinchbeck - From Cultural Catalyst to Capitalist Co-optation: Reflections on Psychedelic Science, AI, and Idealist Monism
In this expansive episode of Psychedelics Today, Joe Moore sits down with author and cultural theorist Daniel Pinchbeck to explore the evolving—and increasingly contested—role of psychedelics in society. From the hopeful spirit of transformation that animated earlier psychedelic ... Show More
1h 9m
Jul 3
PT 612 - Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning
In this wide-ranging conversation, journalist Mattha Busby joins Joe Moore to reflect on the shifting tone of the psychedelic movement in the wake of Psychedelic Science 2025. Based in Vancouver, Mattha has written for The Guardian, VICE, Esquire, TIME, and Wired, bringing a uniq ... Show More
1h 16m
Jul 1
PT 611 - Dylan Beynon - Mindbloom
Dylan Beynon: At-Home Ketamine Therapy, Big Pharma Pushback, and the Future of Psychedelic Accessibility In this episode, Joe Moore welcomes Dylan Beynon, CEO and Founder of Mindbloom, one of the largest providers of legal, at-home ketamine therapy in the U.S. Dylan shares the de ... Show More
1h 33m
Recommended Episodes
Sep 2021
Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders
This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and L ... Show More
2h 49m
Jun 2020
17. Veterans & Psychedelics part 3 – From Shock to Awe with Mitch Schultz
From an early age, Mitch Schultz's curiosity of the unknown universe forged his path in storytelling. His work as a transmedia producer, UX designer, and educator explores the inherent connections among consciousness, nature, culture, and the evolving human mythology.The Document ... Show More
32m 30s
May 2023
Dr. Robin Carhart-Harris: The Science of Psychedelics for Mental Health
In this episode, my guest is Robin Carhart-Harris, PhD, distinguished professor of neurology and psychiatry at the University of California, San Francisco. He is one of leading researchers in the study of how psychedelics such as psilocybin, LSD and DMT can change the human brain ... Show More
2h 32m
Nov 2016
Mushrooms 101: Everything You Need To Know About The Psilocybin Psychedelics That Are Taking The Health World By Storm.
This is a special Premium audio episode. Click here to activate a Premium subscription to the BenGreenfieldFitness show and access this and over 300 additional hidden audios, videos, pdf's and more! Psychedelic drugs such as MDMA (AKA "Ecstacy") LSD and Psilocybin (AKA “magic” mu ... Show More
1h 3m
Jan 2023
What Promise Do Psychedelics Hold As Therapeutics?
When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ... Show More
34m 17s
Apr 2023
#189 The Future Of Psychedelic Assisted Therapies with Tania De Jong
Tania De Jong from Mind Medicine Australia joins Mason for another inspiring and informative conversation on the topic of psychedelic assisted therapies. In the time since Tania was last on the show, the TGA, Australia's Therapeutic Goods Administration, made the monumental decis ... Show More
41m 57s
Jun 2020
Microdosing, Biohacking Plant Medicines, Psychedelic-Enhanced Psychotherapy & More - How "Field Trip Health" Works For Ketamine, MDMA, DMT, Psilocybin & Beyond!
bengreenfieldfitness.com/fieldtrip Field Trip Psychedelics Inc. is the world's first mental wellness company focused on psychedelics and psychedelic-enhanced psychotherapy, is beginning to open the first medical centers - first in Toronto, New York and LA - dedicated exclusively ... Show More
1h 1m
Aug 2022
Psychedelic-Assisted Therapy with Dr. Albert Garcia Romeu
There’s been an explosion of interest in psychedelics over the last 10 years, and phrases like “psychedelic-assisted therapy” have gone from the relative fringes of the mental health conversation to bursting into the mainstream. Alongside a great deal of hype is a growing body of ... Show More
1h 8m
Nov 2022
What Promise Do Psychedelics Hold As Therapeutics?
When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ... Show More
33m 13s